Return On Equity of Adverum Biotechnologies, Inc. from 31 Mar 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Adverum Biotechnologies, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2015 to 30 Sep 2025.
  • Adverum Biotechnologies, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -3476%, a 3517% decline year-over-year.
  • Adverum Biotechnologies, Inc. annual Return On Equity for 2024 was -109%, a 7.4% increase from 2023.
  • Adverum Biotechnologies, Inc. annual Return On Equity for 2023 was -118%, a 73% decline from 2022.
  • Adverum Biotechnologies, Inc. annual Return On Equity for 2022 was -68%, a 71% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Adverum Biotechnologies, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -3476% -3380% -3517% 01 Jul 2025 30 Sep 2025
Q2 2025 -366% -265% -261% 01 Apr 2025 30 Jun 2025
Q1 2025 -176% -68% -63% 01 Jan 2025 31 Mar 2025
Q4 2024 -109% +8.7% +7.4% 01 Oct 2024 31 Dec 2024
Q3 2024 -96% +4.6% +4.6% 01 Jul 2024 30 Sep 2024
Q2 2024 -101% -16% -18% 01 Apr 2024 30 Jun 2024
Q1 2024 -108% -31% -40% 01 Jan 2024 31 Mar 2024
Q4 2023 -118% -50% -73% 01 Oct 2023 31 Dec 2023
Q3 2023 -101% -41% -70% 01 Jul 2023 30 Sep 2023
Q2 2023 -86% -34% -65% 01 Apr 2023 30 Jun 2023
Q1 2023 -77% -31% -65% 01 Jan 2023 31 Mar 2023
Q4 2022 -68% -28% -71% 01 Oct 2022 31 Dec 2022
Q3 2022 -59% -22% -57% 01 Jul 2022 30 Sep 2022
Q2 2022 -52% -19% -59% 01 Apr 2022 30 Jun 2022
Q1 2022 -47% -16% -52% 01 Jan 2022 31 Mar 2022
Q4 2021 -40% -8.3% -26% 01 Oct 2021 31 Dec 2021
Q3 2021 -38% -5.6% -17% 01 Jul 2021 30 Sep 2021
Q2 2021 -33% +5% +13% 01 Apr 2021 30 Jun 2021
Q1 2021 -31% +4.7% +13% 01 Jan 2021 31 Mar 2021
Q4 2020 -32% +5% +14% 01 Oct 2020 31 Dec 2020
Q3 2020 -32% +1.3% +3.8% 01 Jul 2020 30 Sep 2020
Q2 2020 -38% -3.9% -12% 01 Apr 2020 30 Jun 2020
Q1 2020 -36% -2.2% -6.5% 01 Jan 2020 31 Mar 2020
Q4 2019 -37% -4.2% -13% 01 Oct 2019 31 Dec 2019
Q3 2019 -33% -0.84% -2.6% 01 Jul 2019 30 Sep 2019
Q2 2019 -34% -3.2% -10% 01 Apr 2019 30 Jun 2019
Q1 2019 -33% -4.8% -17% 01 Jan 2019 31 Mar 2019
Q4 2018 -32% -2.8% -9.5% 01 Oct 2018 31 Dec 2018
Q3 2018 -33% -0.38% -1.2% 01 Jul 2018 30 Sep 2018
Q2 2018 -31% -0.22% -0.72% 01 Apr 2018 30 Jun 2018
Q1 2018 -29% +22% +44% 01 Jan 2018 31 Mar 2018
Q4 2017 -30% +19% +39% 01 Oct 2017 31 Dec 2017
Q3 2017 -32% +11% +25% 01 Jul 2017 30 Sep 2017
Q2 2017 -30% +12% +28% 01 Apr 2017 30 Jun 2017
Q1 2017 -51% -30% -145% 01 Jan 2017 31 Mar 2017
Q4 2016 -48% -31% -171% 01 Oct 2016 31 Dec 2016
Q3 2016 -43% -25% -137% 01 Jul 2016 30 Sep 2016
Q2 2016 -42% -24% -136% 01 Apr 2016 30 Jun 2016
Q1 2016 -21% +2.6% +11% 01 Jan 2016 31 Mar 2016
Q4 2015 -18% 01 Oct 2015 31 Dec 2015
Q3 2015 -18% 01 Jul 2015 30 Sep 2015
Q2 2015 -18% 01 Apr 2015 30 Jun 2015
Q1 2015 -23% 01 Jan 2015 31 Mar 2015

Adverum Biotechnologies, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -109% +8.7% +7.4% 01 Jan 2024 31 Dec 2024
2023 -118% -50% -73% 01 Jan 2023 31 Dec 2023
2022 -68% -28% -71% 01 Jan 2022 31 Dec 2022
2021 -40% -8.3% -26% 01 Jan 2021 31 Dec 2021
2020 -32% +5% +14% 01 Jan 2020 31 Dec 2020
2019 -37% -4.2% -13% 01 Jan 2019 31 Dec 2019
2018 -32% -2.8% -9.5% 01 Jan 2018 31 Dec 2018
2017 -30% +19% +39% 01 Jan 2017 31 Dec 2017
2016 -48% -31% -171% 01 Jan 2016 31 Dec 2016
2015 -18% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.